Tag Archives: manipulated

FDA ready to crack down as Novartis reveals manipulated Zolgensma data

Novartis’ spinal muscular atrophy gene therapy Zolgensma made all kinds of headlines leading up to and following its approval. Now, it’s making just the kind of headlines no drug company wants to be caught up in. On Tuesday, the FDA said Novartis submitted a drug application with manipulated data and didn’t inform regulators of the issue until one month… Read More »